Gilead Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO

Daniel P. O'Day

CEODaniel P. O'Day

Employees

18,000

Employees18,000

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1987

Founded1987

Employees

18,000

Employees18,000

GILD Key Statistics

Market cap

81.59B

Market cap81.59B

Price-Earnings ratio

182.72

Price-Earnings ratio182.72

Dividend yield

4.61%

Dividend yield4.61%

Average volume

8.64M

Average volume8.64M

High today

$65.80

High today$65.80

Low today

$65.80

Low today$65.80

Open price

$65.92

Open price$65.92

Volume

2.24K

Volume2.24K

52 Week high

$87.87

52 Week high$87.87

52 Week low

$64.33

52 Week low$64.33

GILD News

Benzinga 2d

Gilead Sciences Unusual Options Activity For May 06 - Gilead Sciences - Benzinga

Loading... Loading... Financial giants have made a conspicuous bearish move on Gilead Sciences. Our analysis of options history for Gilead Sciences GILD reveal...

Benzinga 2d

How Is The Market Feeling About Gilead Sciences? - Gilead Sciences - Benzinga

Loading... Loading... Gilead Sciences's GILD short percent of float has risen 4.62% since its last report. The company recently reported that it has 22.57 mill...

Yahoo Finance 5d

Forbes Has Listed Gilead as One of America's Best Employers for Diversity - Yahoo Finance

NORTHAMPTON, MA / ACCESSWIRE / May 3, 2024 / Gilead Sciences Forbes has listed Gilead as one of America's Best Employers for Diversity. We believe that by cham...

Analyst ratings

55%

of 33 ratings

Buy

45.5%

Hold

54.5%

Sell

More GILD News

Yahoo Finance 5d

The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine - Yahoo Finance

For Immediate Release Chicago, IL – May 3, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research anal...

Simply Wall St 6d

We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s CEO Compensation - Simply Wall St

Key Insights Gilead Sciences' Annual General Meeting to take place on 8th of May Total pay for CEO Dan O'Day includes US$1.74m salary The total compensation...